In vivo selectivity of nonsteroidal antiinflammatory drugs and gastrointestinal ulcers in rats

被引:31
作者
Laudanno, OM [1 ]
Cesolari, JA [1 ]
Esnarriaga, J [1 ]
San Miguel, P [1 ]
Bedini, OA [1 ]
机构
[1] Univ Nacl Rosario, Fac Med, Cathedras Gastroenterol & Histol, Dept Expt Gastroenterol, RA-2000 Rosario, Argentina
关键词
COX-1; COX-2; NSAIDs; aceclofenac; meloxicam; nabumetone; nimesulide; paracetamol;
D O I
10.1023/A:1005508120776
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
The aim of the present work was to study in vivo COX-2-COX-1 selectivity of 16 nonsteroidal anti-inflammatory drugs (NSAIDs) in equipotent ulcerogenic doses in two in vivo experimental models. Indomethacin, ibuprofen, nimesulide, aceclofenac, aspirin, sodium diclofenac, meloxicam, naproxene, paracetamol, piroxicam, tenoxicam, nabumetone, ketoprofen, mefenamic acid, etodolac, and ketorolac were administered to female Wistar rats (N = 10 each group). In experiment I, solid food plus subcutaneous NSAIDs were given. In experiment II, NSAIDs were given by oral gavage and in bolus. Macroscopic gastric antral ulcer area (30%) and intestinal erosiva area (295 mm2) in experiment I and necrotic gastric fundus area (65%) and erosive intestinal area (182 mm2), "in vivo" the NSAIDs COX-1 was showed. Neutrofilia assessed in gastric intestinal mucosa where also ibuprofen and paracetamol not given neotrophilic infiltration. In conclusion, COX-2-COX-1 selectivity was demonstrated in vivo with the drugs aceclofenac, nabumetone, meloxicam, nimesulide, and paracetamol.
引用
收藏
页码:1359 / 1365
页数:7
相关论文
共 51 条
[1]   COMPARISON OF THE GASTROINTESTINAL SIDE-EFFECTS OF NAPROXEN FORMULATED AS PLAIN TABLETS, ENTERIC-COATED TABLETS, OR ENTERIC-COATED GRANULES IN CAPSULES [J].
AABAKKEN, L ;
BJORNBETH, BA ;
HOFSTAD, B ;
OLAUSSEN, B ;
LARSEN, S ;
OSNES, M .
SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY, 1989, 24 :65-73
[2]  
AKARASEREENONT P, 1994, BR J PHARM S, V112, P183
[3]   Gastric mucosal contraction and vascular injury induced by indomethacin precede neutrophil infiltration in the rat [J].
Anthony, A ;
Sim, R ;
Dhillon, AP ;
Pounder, RE ;
Wakefield, AJ .
GUT, 1996, 39 (03) :363-368
[4]  
BEDINI OA, 1997, ACTA GASTROENT LA S3, V27, P183
[5]   NSAIDS, COX-2 INHIBITORS, AND THE GUT [J].
BENNETT, A ;
TAVARES, IA .
LANCET, 1995, 346 (8982) :1105-1105
[6]  
CHAN CC, 1995, J EXP PHARM THER, V33, P1609
[7]   Meloxican: Influence on arachidonic acid metabolism .2. In vivo findings [J].
Engelhardt, G ;
Bogel, R ;
Schnitzler, C ;
Utzmann, R .
BIOCHEMICAL PHARMACOLOGY, 1996, 51 (01) :29-38
[8]  
ENGELHARDT G, 1994, EUR J CLIN PHARMACOL, V47, pA98
[9]  
FU JY, 1990, J BIOL CHEM, V265, P16737
[10]   NS-398, A NEW ANTIINFLAMMATORY AGENT, SELECTIVELY INHIBITS PROSTAGLANDIN-G/H SYNTHASE CYCLOOXYGENASE (COX-2) ACTIVITY IN-VITRO [J].
FUTAKI, N ;
TAKAHASHI, S ;
YOKOYAMA, M ;
ARAI, I ;
HIGUCHI, S ;
OTOMO, S .
PROSTAGLANDINS, 1994, 47 (01) :55-59